Liquid Biopsy Market Worth $10.0 Billion by 2027 - Exclusive Report by MarketsandMarkets™
In August 2022, Thermo Fisher Scientific Inc. (US) launched the first NGS-based tests to support both DNA and RNA input. The Ion Torrent Oncomine Myeloid MRD Assays (RUO) provide comprehensive and highly sensitive myeloid measurable residual (MDR) assessments from blood and bone marrow samples.
View full press release